v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]        
Revenues $ 777,457 $ 349,247 $ 2,754,463 $ 1,850,673
Cost of Sales 356,731 130,614 1,660,971 1,116,398
Gross Profit 420,726 218,633 1,093,492 734,275
General and Administrative Expenses        
Stock compensation and stock issued for services 2,350 48,034 2,778,550 2,055,726
Asset impairment expense 2,000,287 2,000,287
General and administrative 1,697,410 1,662,359 4,347,555 4,263,887
Total General and Administrative Expenses 1,699,760 3,710,680 7,126,105 8,319,900
Loss from Operations (1,279,034) (3,492,047) (6,032,613) (7,585,625)
Other Income (Expense)        
Other income 141,017 141,017 3,049
Expenses related to convertible notes payable:        
Change in fair value of derivative liability 343,000 695,300 (3,153,583) 2,717,557
Interest accretion (603,852) (766,603) (1,412,705)
Interest expense related to Equity Purchase Agreement (Note 13) (1,805,687) (6,807,587)
Interest expense (289,585) (1,860,498) (7,173,779) (3,822,927)
Total Other Income (Expense) (1,611,255) (1,769,050) (17,760,535) (2,515,026)
Net Loss before Income Taxes (2,890,289) (5,261,097) (23,793,148) (10,100,651)
Income taxes (Note 11)
Net Loss $ (2,890,289) $ (5,261,097) $ (23,793,148) $ (10,100,651)
Net Basic and Fully Diluted Loss Per Share $ (0.001) $ (0.150) $ (0.008) $ (0.470)
Weighted average common shares outstanding        
Basic 2,822,806,425 35,520,434 2,221,202,596 21,547,126
Fully diluted 3,387,367,710 585,972,958 3,433,133,044 339,856,357